IBM to wind down Watson's work in AI-based drug discovery: report | Fierce Biotech
IBM to wind down Watson's work in AI-based drug discovery: report | Fierce Biotech
IBM is ending new sales its Watson programs aimed at artificial intelligence-based drug discovery and development due to poor financial returns, …
Link to Full Article: IBM to wind down Watson's work in AI-based drug discovery: report | Fierce Biotech